Total investments received (USD): 40.58m
Round value (USD): 32.47m
Round investors:
Boehringer Ingelheim Venture Fund
Novo A/S
Wren Capital
Evotec AG
Animatrix Capital
Company: Centauri Therapeutics
Industry:
Biotech
Health services









Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain